期刊文献+

妇科再造丸对E_2、P负荷诱导实验性大鼠子宫肌瘤的抑制作用 被引量:6

The inhibitory effect of FKW on E_2 and P in the experimental rat uterine leiomyoma
下载PDF
导出
摘要 目的:分析妇科再造丸(FKW)对雌二醇(E2)、孕激素(P)负荷诱导实验性大鼠子宫肌瘤的抑制作用,为临床提供依据。方法:通过乙烯雌酚以及黄体酮进行诱导实验性大鼠子宫肌瘤模型,记录妇科再造丸对于子宫、子宫横径、卵巢系数和子宫平滑肌厚度的影响,通过放射免疫法对妇科再造丸对于孕激素、促黄体生成素、血清雌激素、促卵泡生成素水平的影响。结果:妇科再造丸能够使子宫系数下降,使子宫平滑肌厚度以及子宫横径降低,和模型组对比,差异具有统计学意义(P<0.05);妇科再造丸能够明显提高促黄体生成素以及促卵泡生成素水平,降低大鼠血清中血清雌激素以及孕激素水平。结论:妇科再造丸对于血清雌激素、孕激素负荷诱导实验性大鼠子宫肌瘤具有显著的抑制作用,作用机制可能和改善性腺轴功能状态有关。 Objective To study the inhibitory effect of FKW in the treatment of estradiol( E2) and progesterone( P) in rats,and to provide evidence for clinical treatment. Method To induce the rat model of uterine leiomyoma by diethylstilbestrol and progesterone,recorded FKW of uterus,uterine transverse diameter,ovary diameter coefficient and the thickness of the uterine smooth muscle. The influence of FKW for progesterone and luteinizing hormone,estrogen,serum FSH levels by radioimmunoassay in gynecology. Results The uterine smooth muscle thickness and the transverse diameter of the uterus decreased,and the difference between the model group and the model group was statistically significant( P〈0. 05). FKW can obviously improve the LH and FSH levels,lower serum estrogen and progesterone levels in serum of rats. Conclusion FKW has a significant inhibitory effect on the serum estrogen and progesterone load in the experimental rats,and the mechanism may be related to the improvement of the functional status of gonadal axis.
作者 赵燕
出处 《吉林医学》 CAS 2016年第10期2395-2396,共2页 Jilin Medical Journal
关键词 妇科再造丸 子宫肌瘤 血清雌激素 孕激素 FKW Uterine fibroids Serum estrogen Progesterone
  • 相关文献

参考文献6

二级参考文献25

  • 1黄蓉,福田淳,田中俊成.促性腺激素释放激素激动剂对子宫肌瘤细胞泌乳素生成的作用(英文)[J].中国现代医学杂志,2004,14(14):35-40. 被引量:2
  • 2孟金凤.消极情绪对乳腺疾病的影响[J].中国妇幼保健,2005,20(20):2663-2664. 被引量:10
  • 3刘映霞,陈文萍,付清梅,蔡宇.子宫肌瘤病因分析及其大鼠模型的制备研究[J].国际医药卫生导报,2006,12(15):9-10. 被引量:4
  • 4Rein MS,Barbieri RL, Friedman AJ. Progesterone: A critical role in the pathogensis of uterin myomas[J]. AM J Obs Gyn, 1995,172:14.
  • 5Murphy AA, Kette LM, Morales AJ, et al. Regression of uterine leiomyoma in response to the antiprogoesterone Ru486[J].J Clin Endocrine Metab, 1993, 76:516.
  • 6Friedman AJ, Barbieri RL, Doubilet PM, et al. A randomized, double blind trial to a hormone agonist ( leuprolide ) gonadotropin releasing with or without medroxyprogesterone acctate in the treatment of leiomyomata uteri [J]. Fertil Steril, 1988,49:404.
  • 7Kawaguchi D, et al. Mitotic acticity in uterine leiomyoma during the menstrual cycle [J]. Am J Obstet Gynecol, 1989,160-637.
  • 8ShimomuraY, MatsuoH, SamotoT, et al. Up-regulation by proges-terone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma[J].J Clin Endocrinol Metab, 1998,83 (6) : 2192.
  • 9Fujii MD. Adenomatoid tumor-like structures in the subperitoneal nodules produced by sex steroids [J]. Am J Obstet Gynecol, 1983,145 : 7.
  • 10钟蕙芳,实用妇产科杂志,1997年,13卷,148页

共引文献109

同被引文献79

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部